Intercell AG Sees U.S. JE Vaccine Approval in Early 2009

VIENNA, Dec 29 (Reuters) - Austrian biotech firm Intercell (ICEL.VI) said on Monday it expects U.S. approval for its Japanese Encephalitis (JE) vaccine to move into early 2009, later than expected.